--2024/Q4-- / 830.000--
--2024/Q3-- / 830.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--
US Stock MarketDetailed Quotes
ALT Altimmune
- 6.170
- -0.160-2.53%
Close Aug 9 16:00 ET
- 6.150
- -0.020-0.32%
Post 19:57 ET
438.51MMarket Cap-3785P/E (TTM)
6.600High6.010Low2.55MVolume6.400Open6.330Pre Close15.72MTurnover3.61%Turnover RatioLossP/E (Static)71.07MShares14.84052wk High2.88P/B435.30MFloat Cap2.09052wk Low--Dividend TTM70.55MShs Float978.000Historical High--Div YieldTTM9.32%Amplitude-1731.000Historical Low6.176Avg Price1Lot Size
Altimmune Key Stats
Altimmune Earnings Date
Currency: USD
Period
Q2 FY2024 Earnings
Aug 8, 2024
Revenue(YoY)
5.00K
-16.67%EPS(YoY)
-0.35
-9.37%Analyst Rating
Aug 9, 2024
Altimmune Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Altimmune Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
